Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Terms of Use
Privacy Policy
Sitemap
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Breast Cancer
•
Medical Oncology
•
Breast Cancer, Non-metastatic
What neoadjuvant chemo regimen would you recommend for a patient with LN positive TNBC and a history of CVA, neuropathy, and risk factors for heart disease but normal echo?
Related Questions
Would you offer adjuvant abemaciclib to node-positive patients with low ER expression?
Would you offer neoadjuvant chemotherapy to cT1c N0 triple negative breast cancer with metaplastic features in a young patient?
Would you recommend tamoxifen x 5 years following mastectomy in a male with pure DCIS?
How would you approach adjuvant therapy for a post-menopausal women with cT2 cN0 TNBC on biopsy s/p neoadjuvant chemotherapy and mastectomy who is later found to have RCB2 HR+ breast cancer on surgical pathology?
What adjuvant chemotherapy regimen do you recommend for a patient with T1cN0 TNBC?
How do you approach treatment in premenopausal patients who develop a contralateral HR+ breast cancer while already on tamoxifen and ovarian function suppression?
What adjuvant therapy would you offer a TNBC patient with residual disease after receiving the neoadjuvant KEYNOTE-522 regimen?
Can tamoxifen be safely prescribed for breast cancer patients with cirrhosis?
Would you offer adjuvant AI + abemaciclib to a post-menopausal, node + luminal A breast cancer that did not require chemotherapy per Oncotype, yet still met criteria per monarchE?
How have you been incorporating Abemaciclib into the adjuvant management of high risk node positive HR+ breast cancer?
